BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 232024)

  • 1. Reactive hyper-reninaemia to angiotensin blockade identifies renovascular hypertension.
    Case DB; Atlas SA; Laragh JH
    Clin Sci (Lond); 1979 Dec; 57 Suppl 5():313s-316s. PubMed ID: 232024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive hyperreninemia in renovascular hypertension after angiotensin blockage with saralasin or converting enzyme inhibitor.
    Case DB; Laragh JH
    Ann Intern Med; 1979 Aug; 91(2):153-60. PubMed ID: 464461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 12-hour infusions of saralasin or captopril on blood pressure in hypertensive conscious rats. Relationship to plasma renin, duration of hypertension, and effect of unclipping.
    Bing RF; Russell GI; Swales JD; Thurston H
    J Lab Clin Med; 1981 Aug; 98(2):302-10. PubMed ID: 7019368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET; Stinson J; Ramirez G
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of chronic renovascular hypertension to surgical correction or prolonged blockade of the renin-angiotensin system by two inhibitors in the rat.
    Thurston H; Bing RF; Marks ES; Swales JD
    Clin Sci (Lond); 1980 Jan; 58(1):15-20. PubMed ID: 6986225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-negative saralasin responses in renovascular hypertension.
    Stokes GS; MacCarthy EP; Frost GW; Sheil AG
    Br J Urol; 1979 Apr; 51(2):92-9. PubMed ID: 465980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A screening test for renovascular hypertension by means of orally active angiotensin I converting enzyme inhibitor, captopril (SQ 14225).
    Imai Y; Abe K; Otsuka Y; Sakurai Y; Yoshinaga K
    Tohoku J Exp Med; 1980 Jul; 131(3):311-2. PubMed ID: 6998048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of renovascular hypertension with angiotensin II blockade.
    Baer L; Parra-Carrilo JZ; Radichevich I; Williams GS
    Ann Intern Med; 1977 Mar; 86(3):257-60. PubMed ID: 842983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saralasin infusion in screening patients for renovascular hypertension.
    Krakoff LR; Ribeiro AB; Gorkin JU; Felton KR
    Am J Cardiol; 1980 Mar; 45(3):609-13. PubMed ID: 6986750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin.
    Case DB; Wallace JM; Keim HJ; Weber MA; Drayer JI; White RP; Sealey JE; Laragh JH
    Am J Med; 1976 Nov; 61(5):790-6. PubMed ID: 185903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maximal discrimination of renovascular from essential hypertension by the saralasin test.
    Maxwell MH; Varady P; Zawada ET; Burkhalter JF; Waks U; Marks L
    Clin Sci Mol Med Suppl; 1978 Dec; 4():297s-299s. PubMed ID: 282071
    [No Abstract]   [Full Text] [Related]  

  • 12. Angiotensin blockade in renovascular hypertension: a controlled, prospective study.
    Marks LS; Maxwell MH; Gross C; Waks U; Kaufman JJ
    Br J Urol; 1977 Jun; 49(3):181-8. PubMed ID: 334316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative study of an angiotensin-II analog and a converting enzyme inhibitor.
    Fagard RH; Amery AK; Lijnen PJ; Reybrouck TM
    Kidney Int; 1980 May; 17(5):647-53. PubMed ID: 6249956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renovascular hypertension: prediction of surgical treatment by angiotensin II blockade and saralasin (author's transl)].
    Mimran A; Deschodt G; Barjon P; Mary H; Thevenet A
    Nouv Presse Med; 1978 Dec; 7(43):3889-93. PubMed ID: 733540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of converting enzyme and angiotensin II inhibitors in chronic one kidney bipolar ligated hypertension.
    Loyke HF
    Pharmacol Res Commun; 1981 May; 13(5):501-9. PubMed ID: 6270704
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiotensin II blockade before and after marked sodium depletion in patients with hypertension.
    Van Hoogdalem P; Donker AJ; Leenen FH
    Clin Sci Mol Med; 1978 Jan; 54(1):75-83. PubMed ID: 620496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of captopril in the diagnosis of renal hypertension.
    McGrath BP; Matthews PG; Johnston CI
    Aust N Z J Med; 1981 Aug; 11(4):359-63. PubMed ID: 7030291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Saralasin infusion in renovascular and essential hypertension.
    Thien T; Hoefnagels WH
    Neth J Med; 1980; 23(2):68-73. PubMed ID: 6990282
    [No Abstract]   [Full Text] [Related]  

  • 20. Use of saralasin to detect renovascular hypertension in childhood.
    Gillespie L; Ehrlich RM; Marks LS; Maxwell MH; Kaufman JJ
    Urology; 1980 Nov; 16(5):453-6. PubMed ID: 7003900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.